Aledade Partners Achieve Superior Hypertension Control Outperforming Large Health Systems in New Case Study Aledade, a physician-led, national leader in value-based care, announced the results of a new case study demonstrating how its network of primary care clinicians is successfully controlling hypertension…
Nordic Cold Chain Solutions Launches GLP-1 & Small-Format Packaging Innovation Lab Nordic Cold Chain Solutions today announced the launch of its GLP-1 & Small-Format Packaging Innovation Lab, a customer-first initiative designed to help specialty pharmacies, pharmaceutical manufacturers, and e-commerce leaders…
Drug Farm Announces U.S. FDA Orphan Drug Designation for DF-003 for the Treatment of ROSAH Syndrome Drug Farm today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to DF-003, the company’s investigational small…
Xaira Therapeutics Announces the Appointment of Rachel Lane, Ph.D., as Senior Vice President, Business Development and Operations Xaira Therapeutics announced the appointment of Dr. Rachel Lane as Senior Vice President, Business Development and Operations, reporting to President and COO Jeff…
First Patient Dosed in New Study Investigating Novel Made-In-Canada Drug Candidate to Prevent Brain Injury in Hemodialysis Patients The first patient has been treated in a unique clinical trial to evaluate the safety and efficacy of a novel pharmacologic intervention…
Skeyeon Secures Key Patent for Very-Low Earth Orbit Satellite Constellations with Onboard Imaging and Direct-to-Ground Data Delivery Enabling Near-Real-Time Earth Observation Skeyeon, Inc., today announced that the United States Patent and Trademark Office has issued U.S. Patent No. 12,559,451 B2,…
Artis BioSolutions Establishes U.S.-based Synthetic DNA Manufacturing Hub in Boston Artis BioSolutions an advanced therapies company dedicated to integrating the specialized technologies, infrastructure, and manufacturing capabilities required to deliver next-generation genetic medicines, today announced the establishment of new synthetic DNA…
Omeros Announces Upcoming Presentation at EBMT 2026 Highlighting Advances in TA-TMA Treatment Omeros Corporation (NASDAQ: OMER) today announced that it will host an industry session at the 52nd Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) on…
Prothena Partners Present Data Supporting Next Generation Treatments for Parkinson’s and Alzheimer’s Disease at AD/PD™ 2026 Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced partner…
Sakura Finetek Global and Hamamatsu Photonics K.K. Global Alliance Press Release Sakura Finetek Global, a worldwide leader in automated tissue and slide preparation solutions for anatomic pathology, and Hamamatsu Photonics K.K., a global leader in imaging technologies, today announced an…
California Public Utilities Commission Conditionally Approves RNG Procurement Contract from Anaergia’s SoCal Biomethane Facility Anaergia Inc. (“Anaergia” or the “Company”) (TSX: ANRG; OTCQX: ANRGF) reports that the California Public Utilities Commission (“CPUC”) has conditionally approved a long-term biomethane procurement contract…
The 15-20 National Hospital and GenSight Biologics Announce the First Treatments in the French Named Patient Early Access Program (AAC) for GS010/LUMEVOQ® The 15-20 National Hospital (l’Hôpital national des 15-20) in Paris and GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME…